Latamoxef

Latamoxef, also known as moxalactam, is a β-lactam antibiotic. It is a semi-synthetic derivative of the antibiotic amoxicillin, structurally related to the penicillin nucleus. It is used to treat severe bacterial infections caused by susceptible organisms, including infections of the respiratory tract, urinary tract, gastrointestinal tract, skin, and soft tissues. It is administered intravenously or intramuscularly.

Latamoxef, also known as moxalactam, is a broad-spectrum antibiotic belonging to the oxacephem class. Here's a breakdown of its key features:

Function: Latamoxef combats various bacterial infections by interfering with their cell wall synthesis, ultimately killing the bacteria.

Applications: Latamoxef has been used to treat a wide range of bacterial infections, including:

  • Bone and joint infections
  • Gastrointestinal (GI) infections
  • Gynecological infections
  • Meningitis (infection of the meninges surrounding the brain and spinal cord) - Due to its ability to cross the blood-brain barrier, it was particularly promising for this use.
  • Respiratory tract infections
  • Sepsis (bloodstream infection)
  • Skin and soft tissue infections
  • Urinary tract infections (UTIs)

Important Notes:

  • Latamoxef usage might be limited nowadays due to the availability of other antibiotics with similar effectiveness and potentially fewer side effects.
  • It's crucial for doctors to consider factors like the specific type of infection and potential bacterial resistance when choosing Latamoxef as a treatment option.

Administration: Latamoxef is typically administered intravenously (through an IV drip) or intramuscularly (injected into a muscle) for a specific course of treatment determined by a doctor.

Here are some additional points to consider:

  • Latamoxef can cause side effects like nausea, vomiting, diarrhea, rash, and allergic reactions. It's important to be aware of these potential risks and discuss them with your doctor.
  • Like all antibiotics, overuse or misuse of Latamoxef can contribute to antibiotic resistance, making it less effective in the future.
     
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J01 Antibacterials for systemic use
J01D - Other beta-lactam antibacterials
J01DD Third-generation cephalosporins
External Links